Carl M.

Age: 37

Diagnosis: Multiple Sclerosis

Date of Treatment: Sept. 24, 2008

Type of Treatment: Lumbar Puncture

One word to describe treatment and our care while in Mexico is “AMAZING”.  No matter what we wanted it was provided, from the moment we were picked up at the airport until we were taken back for our trip home.

Carl has most improved in his cognitive area.  He is able to hold a conversation and speak in complete sentences to express himself.  He sleeps well and eats even better.  His attitude is good.  His legs seem a little stronger.

This trip and treatment has been a blessing to our family.

This entry was posted on Friday, December 12th, 2008 at 5:59 pm

Cellulogix International and Dr. Casey Nabavi are pleased to announce the recent opening of a clinic in Istanbul, Turkey, where stem cell treatments via IV, subcutaneous injections, and lumbar puncture have been successfully completed. In early 2009, treatment centers will be opening in Berlin, Germany; Moscow, Russia; and Guatemala City, Guatemala.

Dr. Casey Nabavi has been working tirelessly to open clinics globally to make available stem cell treatments to patients worldwide and advance stem cell research.

This entry was posted on Tuesday, December 9th, 2008 at 7:03 pm

Cellulogix International is proud to announce the launch of the new adult stem cell treatment procedure referred to as “Apheresis” methodology.

This procedure involves the extraction of stem cells and Mononuclear cells from peripheral blood utilizing an Apheresis instrument, reconditioning the extracted cells on site and injection of the reconditioned cells back into the patient. This procedure is an effective method of treatment for several conditions including autoimmune disorders.  It is also used as an adjunct to our existing stem cell treatment protocols. Additionally, it has anti-aging applications.

This entry was posted on Friday, December 5th, 2008 at 5:27 pm

Cellulogix Biosciences is the parent of a network of companies in the field of biotechnology.

Cellulogix International falls under this parent company and was designed for the purpose of providing umbilical cord and adult stem cell treatments to patients all over the globe.

Cellulogix International currently has clinics in North and Central America (near the California border in Zona Rio, Mexico and also in Guatemala City, Guatemala)  There is another clinic for European patients located in Istanbul, Turkey.  On the horizon are clinics in Moscow, Russia and Berlin, Germany.

This entry was posted on Thursday, December 4th, 2008 at 4:53 pm

Stem cells are the primordial cells in the human body. The first stem cells occur inside a developing embryo (blastocytes). These stem cells are understood to be totipotent, meaning that they are capable of differentiating into every cell type. They divide, differentiate, and ultimately construct the entire human body.

Stem cell therapy involves the introduction of healthy new stem cells to, potentially, repair, and replace damaged or lost cells. This new technique is being applied to treat a wide range of human conditions, including many types of cancer, infectious diseases like AIDS and hepatitis, diabetes, heart, lung, kidney diseases, many diseases of the eyes like macular degeneration or retinitis pigmentosa, as well as neurological disorders such as Parkinson’s, Lou Gehrig’s disease (ALS), multiple sclerosis and spinal cord injuries. It is also used to treat skin disorders and aging.

This entry was posted on Thursday, December 4th, 2008 at 3:20 am

Cellulogix International Inc. www.cellulogixintl.com launches coalescing enterprise as Regenerative Therapies gains momentum.

Cellulogix International Inc. Montreal, Canada, formally advances its interests in the global Stem Cell Therapy commercial industry.  Known for its advanced applications in human cord blood and in fruitful collaboration with some of the most reliable and reputable biotech companies in Canada, Europe, Russia, South Africa, South America, and the United States to establish protocols to recondition cells that are used in treatments.

With Regenerative Therapies gaining momentum due to the advancement of emerging needs and interests on every continent, Cellulogix International Inc. www.cellulogixintl.com is positioned as the leading commercial provider of therapeutic applications of human cord blood. Research is showing the International demand for a universal product with unlimited and undifferentiated cells, condition specific protocols tailored to each patient, to maximize the targeting of cells to areas of need. With industry trends showing progress in this area, Cellulogix International Inc. www.cellulogixintl.com under the direction of founder Dr. Casey Nabavi is now an established leader and also announces the launch of the new Adult Stem Cell treatment procedure referred to as “Apheresis” methodology which is known for its anti-aging qualities. A universal product from and for the patient donor.

For more information and a consultation with a scientist, please phone 514-448-2199

This entry was posted on Wednesday, December 3rd, 2008 at 11:36 pm

Autism is a brain development disorder characterized by impaired social interaction and communication, and by restricted and repetitive behavior which begin before a child is three years old.

A recent study at Case Western Reserve University found mutations within the ERK ((extracellular signal regulated kinase) signaling pathway appeared to be a common cause for NCFC (neuro-craniofacial-cardiac syndromes) syndromes as well as children with autism due to genetic changes in chromosome 16.

The study, led by Gary Landreth, professor of neurosciences and neurology at the School of Medicine, revealed that was 1 percent of autistic children have either a loss or duplication in a region of Chromosome 16 that encompasses the gene for ERK 1.

This entry was posted on Wednesday, February 20th, 2008 at 5:02 pm